Skip to main content
Livermore
Livermore
ZHEN

Endurant Capital Management LP

SEC CIK
0001633055
Latest filing
May 7, 2024

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
51
−6 vs. Q2 2021
Portfolio value
$329.0M
−$34.8M (−9.6%) vs. Q2 2021
Filed
Nov 15, 2021
SEC
Holdings of Endurant Capital Management LP in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
Invacare Corp461203AJ0CONVERTIBLE BOND–$51.2M15.6%–––
ABBVAbbVie Inc.Stock180,429$19.5M5.9%+94,915+111.0%AddedHistory
HUMHumana IncStock44,022$17.1M5.2%+28,231+178.8%AddedHistory
JNJJohnson & JohnsonStock98,077$15.8M4.8%+65,079+197.2%AddedHistory
HOLXHologic IncCOM200,119$14.8M4.5%+89,279+80.5%AddedHistory
BIOBio-Rad Laboratories, Inc.CL A18,272$13.6M4.1%+6,452+54.6%AddedHistory
BMYBristol Myers Squibb CoStock211,821$12.5M3.8%+110,740+109.6%AddedHistory
ICLRIcon PLCCOM46,720$12.2M3.7%−32,695−41.2%ReducedHistory
THCTenet Healthcare CorpCOM NEW179,288$11.9M3.6%−38,603−17.7%ReducedHistory
SIBNSI-BONE, Inc.COM471,214$10.1M3.1%+431,059+1,073.5%AddedHistory
SYNHSyneos Health, Inc.CL A92,761$8.12M2.5%−37,477−28.8%ReducedHistory
VCYTVeracyte, Inc.COM168,211$7.81M2.4%+28,000+20.0%AddedHistory
CICigna GroupStock36,188$7.24M2.2%−35,668−49.6%ReducedHistory
ELUTElutia Inc.CL A COM952,610$6.63M2.0%+79,451+9.1%AddedHistory
AVTRAvantor, Inc.COM161,963$6.62M2.0%+9,568+6.3%AddedHistory
MCKMcKesson CorpStock32,551$6.49M2.0%+32,551NewHistory
ACHAccendra Health IncStock203,784$6.38M1.9%+136,795+204.2%AddedHistory
RCMR1 RCM Holdco Inc.COM282,911$6.23M1.9%−265,965−48.5%ReducedHistory
Invacare Corp461203AL5NOTE 5.000%11/1–$6.21M1.9%–New–
ATRAptargroup, Inc.Stock51,191$6.11M1.9%+51,191NewHistory
OCULOcular Therapeutix, IncCOM610,401$6.10M1.9%+39,431+6.9%AddedHistory
LHLabcorp Holdings Inc.COM NEW18,829$5.30M1.6%−44,090−70.1%ReducedHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR917,488$4.74M1.4%−621,947−40.4%ReducedHistory
AHCOAdaptHealth Corp.COMMON STOCK194,886$4.54M1.4%+194,886NewHistory
INSMINSMED IncCOM PAR $.01159,903$4.40M1.3%−100,411−38.6%ReducedHistory
RNACCartesian Therapeutics, Inc.COM1,021,501$4.25M1.3%+94,566+10.2%AddedHistory
MTEMMolecular Templates, Inc.COM613,630$4.12M1.3%−134,383−18.0%ReducedHistory
ALBOAlbireo Pharma, Inc.COM117,328$3.66M1.1%+13,816+13.3%AddedHistory
PHASPhaseBio Pharmaceuticals IncCOM1,132,523$3.52M1.1%−997,186−46.8%ReducedHistory
XRAYDentsply Sirona Inc.Stock60,620$3.52M1.1%−43,240−41.6%ReducedHistory
RVTYRevvity, Inc.COM19,264$3.34M1.0%+19,264NewHistory
IOVAIovance Biotherapeutics, Inc.COM131,098$3.23M1.0%−29,264−18.2%ReducedHistory
PRAXPraxis Precision Medicines, Inc.COM153,599$2.84M0.9%−45,966−23.0%ReducedHistory
BDXBecton Dickinson & CoStock11,077$2.72M0.8%+11,077NewHistory
SNYSanofiSPONSORED ADR54,821$2.64M0.8%+54,821NewHistory
CORCencora, Inc.Stock21,430$2.56M0.8%−20,299−48.6%ReducedHistory
RGLSRegulus Therapeutics Inc.COM NEW3,547,208$2.45M0.7%+939,534+36.0%AddedHistory
Bellus Health Inc New07987C204COM NEW389,833$2.39M0.7%−16,704−4.1%Reduced–
DRIODarioHealth Corp.COM NEW150,004$2.05M0.6%−108,770−42.0%ReducedHistory
MREOMereo BioPharma Group plcSPON ADS746,514$1.81M0.5%−10,401−1.4%ReducedHistory
AXSMAxsome Therapeutics, Inc.COM52,048$1.72M0.5%+52,048NewHistory
IMUXImmunic, Inc.COM185,448$1.64M0.5%+8,300+4.7%AddedHistory
MRVIMaravai Lifesciences Holdings, Inc.COM CL A29,838$1.46M0.4%+29,838NewHistory
ACRSAclaris Therapeutics, Inc.COM67,300$1.21M0.4%−52,078−43.6%ReducedHistory
KRYSKrystal Biotech, Inc.COM22,938$1.20M0.4%+22,938NewHistory
BOLTBolt Biotherapeutics, Inc.COM90,041$1.14M0.3%+90,041NewHistory
KLRSKalaris Therapeutics, Inc.COM44,430$1.11M0.3%+44,430NewHistory
XENEXenon Pharmaceuticals Inc.COM62,743$959.0K0.3%+62,743NewHistory
PDCOPatterson Companies, Inc.COM26,799$808.0K0.2%+26,799NewHistory
Celyad Oncology SA151205200ADR145,380$596.0K0.2%−15,311−9.5%Reduced–
IVCInvacare Holdings CorpCOM1,146,068$323.0K0.1%−228,772−16.6%ReducedHistory

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Endurant Capital Management LP in Q3 2021
SecurityClassPutsCalls
SPYSPDR S&P 500 ETF TrustETF$73.8M–
Trillium Therapeutics Inc.89620X506COM NEW–$36.3M

Sold out since Q2 2021 (20)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of Endurant Capital Management LP sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
TMOThermo Fisher Scientific Inc.Stock29,679$15.0M4.1%History
HAEHaemonetics CorpCOM117,904$7.86M2.2%History
EAREargo, Inc.COM193,471$7.72M2.1%History
Trillium Therapeutics Inc.89620X506COM NEW600,788$5.83M1.6%–
INSMED Inc457669AB5NOTE 0.750% 6/05,000,000$5.54M1.5%–
ELVElevance Health, Inc.Stock11,941$4.56M1.3%History
FATEFate Therapeutics IncCOM51,031$4.43M1.2%History
SPRYARS Pharmaceuticals, Inc.COM139,124$4.30M1.2%History
Calliditas Therapeutics AB13124Q106SPONSERED ADS144,393$4.25M1.2%–
MDVLMedAvail Holdings, Inc.COM292,196$3.58M1.0%History
REGNRegeneron Pharmaceuticals, Inc.COM5,563$3.11M0.9%History
TFXTeleflex IncCOM7,501$3.01M0.8%History
SRPTSarepta Therapeutics, Inc.COM28,625$2.23M0.6%History
BAXBaxter International IncStock25,059$2.02M0.6%History
PNTGPennant Group, Inc.COM47,475$1.94M0.5%History
FBRXForte Biosciences, Inc.COM53,369$1.79M0.5%History
VRTXVertex Pharmaceuticals IncStock7,553$1.52M0.4%History
CANOCano Health, Inc.COM CL A62,013$750.0K0.2%History
PRVBProvention Bio, Inc.COM82,960$699.0K0.2%History
XFORX4 Pharmaceuticals, IncCOM70,969$461.0K0.1%History